Barbara Rolando

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 27

Top Topics

African American

Cancer Stem Cells

Metastatic Colorectal Cancer

Top Venues

Molecules (Basel, Switzerland)

Journal of medicinal chemistry

Antioxidants (Basel, Switzerland)

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Tiago Miguel Amaral Carvalho, Madelaine Magalì Audero, Maria Raffaella Greco, Marilena Ardone, Teresa Maggi, Rosanna Mallamaci, Barbara Rolando, Silvia Arpicco, Federico Alessandro Ruffinatti, Alessandra Fiorio Pla, Natalia Prevarskaya, Tomas Koltai, Stephan Joel Reshkin, Rosa Angela Cardone
Tumor Microenvironment Modulates Invadopodia Activity of Non-Selected and Acid-Selected Pancreatic Cancer Cells and Its Sensitivity to Gemcitabine and C18-Gemcitabine. Cells 13 (9) (2024)
Tiago Miguel Amaral Carvalho, Madelaine Magalì Audero, Maria Raffaella Greco, Marilena Ardone, Teresa Maggi, Rosanna Mallamaci, Barbara Rolando, Silvia Arpicco, Federico Alessandro Ruffinatti, Alessandra Fiorio Pla, Natalia Prevarskaya, Tomas Koltai, Stephan Joel Reshkin, Rosa Angela Cardone
Tumor Microenvironment Modulates Invadopodia Activity of Non-Selected and Acid-Selected Pancreatic Cancer Cells and Its Sensitivity to Gemcitabine and C18-Gemcitabine. Cells 13 (9) (2024)
Elisabetta Marini, Barbara Rolando, Federica Sodano, Federica Blua, Giulia Concina, Stefano Guglielmo, Loretta Lazzarato, Konstantin Chegaev
Comparative Study of Different H 2 S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Federica Sodano, Barbara Rolando, Loretta Lazzarato, Costanzo Costamagna, Mariacristina Failla, Chiara Riganti, Konstantin Chegaev
Use of Enzymatically Activated Carbon Monoxide Donors for Sensitizing Drug-Resistant Tumor Cells. International journal of molecular sciences 24 (14) (2023)
Loretta Lazzarato, Laura Bianchi, Annapaola Andolfo, Agnese Granata, Matteo Lombardi, Matteo Sinelli, Barbara Rolando, Marina Carini, Alberto Corsini, Roberta Fruttero, Lorenzo Arnaboldi
Proteomics Studies Suggest That Nitric Oxide Donor Furoxans Inhibit In Vitro Vascular Smooth Muscle Cell Proliferation by Nitric Oxide-Independent Mechanisms. Molecules (Basel, Switzerland) 28 (15) (2023)
Elisabetta Marini, Barbara Rolando, Federica Sodano, Federica Blua, Giulia Concina, Stefano Guglielmo, Loretta Lazzarato, Konstantin Chegaev
Comparative Study of Different H 2 S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Elisabetta Marini, Barbara Rolando, Federica Sodano, Federica Blua, Giulia Concina, Stefano Guglielmo, Loretta Lazzarato, Konstantin Chegaev
Comparative Study of Different H 2 S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Elisabetta Marini, Marco Marino, Giulia Gionfriddo, Federica Maione, Marta Pandini, Daniele Oddo, Marta Giorgis, Barbara Rolando, Federica Blua, Simone Gastaldi, Serena Marchiò, Sandra Kovachka, Francesca Spyrakis, Eleonora Gianquinto, Federica Di Nicolantonio, Massimo Bertinaria
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAF V600E Protein. Molecules (Basel, Switzerland) 27 (23) (2022)
Stefano Sainas, Marta Giorgis, Paola Circosta, Giulio Poli, Marta Alberti, Alice Passoni, Valentina Gaidano, Agnese C Pippione, Nicoletta Vitale, Davide Bonanni, Barbara Rolando, Alessandro Cignetti, Cristina Ramondetti, Alessia Lanno, Davide M Ferraris, Barbara Canepa, Barbara Buccinnà, Marco Piccinini, Menico Rizzi, Giuseppe Saglio, Salam Al-Karadaghi, Donatella Boschi, Riccardo Miggiano, Tiziano Tuccinardi, Marco Lucio Lolli
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a ]pyridine Scaffold: SAR of the Aryloxyaryl Moiety. Journal of medicinal chemistry 65 (19) (2022)
Eleonora Gianquinto, Federica Sodano, Barbara Rolando, Magdalena Kostrzewa, Marco Allarà, Ali Mokhtar Mahmoud, Poulami Kumar, Francesca Spyrakis, Alessia Ligresti, Konstantin Chegaev
N -[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation. Molecules (Basel, Switzerland) 27 (23) (2022)
Eleonora Gianquinto, Federica Sodano, Barbara Rolando, Magdalena Kostrzewa, Marco Allarà, Ali Mokhtar Mahmoud, Poulami Kumar, Francesca Spyrakis, Alessia Ligresti, Konstantin Chegaev
N -[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation. Molecules (Basel, Switzerland) 27 (23) (2022)
Elisabetta Marini, Marco Marino, Giulia Gionfriddo, Federica Maione, Marta Pandini, Daniele Oddo, Marta Giorgis, Barbara Rolando, Federica Blua, Simone Gastaldi, Serena Marchiò, Sandra Kovachka, Francesca Spyrakis, Eleonora Gianquinto, Federica Di Nicolantonio, Massimo Bertinaria
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAF V600E Protein. Molecules (Basel, Switzerland) 27 (23) (2022)
Elisabetta Marini, Marco Marino, Giulia Gionfriddo, Federica Maione, Marta Pandini, Daniele Oddo, Marta Giorgis, Barbara Rolando, Federica Blua, Simone Gastaldi, Serena Marchiò, Sandra Kovachka, Francesca Spyrakis, Eleonora Gianquinto, Federica Di Nicolantonio, Massimo Bertinaria
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAF V600E Protein. Molecules (Basel, Switzerland) 27 (23) (2022)
Eleonora Gianquinto, Federica Sodano, Barbara Rolando, Magdalena Kostrzewa, Marco Allarà, Ali Mokhtar Mahmoud, Poulami Kumar, Francesca Spyrakis, Alessia Ligresti, Konstantin Chegaev
N -[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation. Molecules (Basel, Switzerland) 27 (23) (2022)
Federica Sodano, Claudia Cristiano, Barbara Rolando, Elisabetta Marini, Loretta Lazzarato, Mariarosaria Cuozzo, Stefania Albrizio, Roberto Russo, Maria Grazia Rimoli
Galactosylated Prodrugs: A Strategy to Improve the Profile of Nonsteroidal Anti-Inflammatory Drugs. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Eleonora Gianquinto, Federica Sodano, Barbara Rolando, Magdalena Kostrzewa, Marco Allarà, Ali Mokhtar Mahmoud, Poulami Kumar, Francesca Spyrakis, Alessia Ligresti, Konstantin Chegaev
N -[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation. Molecules (Basel, Switzerland) 27 (23) (2022)
Elisabetta Marini, Marco Marino, Giulia Gionfriddo, Federica Maione, Marta Pandini, Daniele Oddo, Marta Giorgis, Barbara Rolando, Federica Blua, Simone Gastaldi, Serena Marchiò, Sandra Kovachka, Francesca Spyrakis, Eleonora Gianquinto, Federica Di Nicolantonio, Massimo Bertinaria
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAF V600E Protein. Molecules (Basel, Switzerland) 27 (23) (2022)
Stefano Sainas, Marta Giorgis, Paola Circosta, Valentina Gaidano, Davide Bonanni, Agnese C Pippione, Renzo Bagnati, Alice Passoni, Yaqi Qiu, Carina Florina Cojocaru, Barbara Canepa, Alessandro Bona, Barbara Rolando, Mariia Mishina, Cristina Ramondetti, Barbara Buccinnà, Marco Piccinini, Mohammad Houshmand, Alessandro Cignetti, Enrico Giraudo, Salam Al-Karadaghi, Donatella Boschi, Giuseppe Saglio, Marco Lucio Lolli
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Biphenyl Moiety. Journal of medicinal chemistry 64 (9) (2021)
Iris Chiara Salaroglio, Carmen Abate, Barbara Rolando, Luigi Battaglia, Elena Gazzano, Elena Colombino, Costanzo Costamagna, Laura Annovazzi, Marta Mellai, Francesco Berardi, Maria Teresa Capucchio, Davide Schiffer, Chiara Riganti
Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells. Molecular pharmaceutics 16 (8) (2019)
Chiara Riganti, Marialessandra Contino, Stefano Guglielmo, Maria G Perrone, Iris C Salaroglio, Vladan Milosevic, Roberta Giampietro, Francesco Leonetti, Barbara Rolando, Loretta Lazzarato, Nicola A Colabufo, Roberta Fruttero
Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells. Journal of medicinal chemistry 62 (2) (2019)
Federica Sodano, Loretta Lazzarato, Barbara Rolando, Francesca Spyrakis, Carmen De Caro, Salvatore Magliocca, Domenica Marabello, Konstantin Chegaev, Elena Gazzano, Chiara Riganti, Antonio Calignano, Roberto Russo, Maria Grazia Rimoli
Paracetamol-Galactose Conjugate: A Novel Prodrug for an Old Analgesic Drug. Molecular pharmaceutics 16 (10) (2019)
Alessandro Giraudo, Jacob Krall, Francesco Bavo, Birgitte Nielsen, Kenneth Thermann Kongstad, Barbara Rolando, Rossella De Blasio, David E Gloriam, Rebekka Löffler, Louise Thiesen, Kasper Harpsøe, Karla A Frydenvang, Donatella Boschi, Petrine Wellendorph, Marco Lucio Lolli, Anders A Jensen, Bente Frølund
Five-Membered N-Heterocyclic Scaffolds as Novel Amino Bioisosteres at γ-Aminobutyric Acid (GABA) Type A Receptors and GABA Transporters. Journal of medicinal chemistry 62 (12) (2019)
Stefano Sainas, Agnese C Pippione, Elisa Lupino, Marta Giorgis, Paola Circosta, Valentina Gaidano, Parveen Goyal, Davide Bonanni, Barbara Rolando, Alessandro Cignetti, Alex Ducime, Mikael Andersson, Michael A Järvå, Rosmarie Friemann, Marco Piccinini, Cristina Ramondetti, Barbara Buccinnà, Salam Al-Karadaghi, Donatella Boschi, Giuseppe Saglio, Marco Lucio Lolli
Correction to Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors. Journal of medicinal chemistry 62 (3) (2019)
Federica Sodano, Barbara Rolando, Francesca Spyrakis, Mariacristina Failla, Loretta Lazzarato, Elena Gazzano, Chiara Riganti, Roberta Fruttero, Alberto Gasco, Salvatore Sortino
Tuning the Hydrophobicity of a Mitochondria-Targeted NO Photodonor. ChemMedChem 13 (12) (2018)
Salvatore Magliocca, Carmen De Caro, Loretta Lazzarato, Roberto Russo, Barbara Rolando, Konstantin Chegaev, Elisabetta Marini, Maria Nieddu, Lucia Burrai, Gianpiero Boatto, Claudia Cristiano, Domenica Marabello, Elena Gazzano, Chiara Riganti, Federica Sodano, Maria Grazia Rimoli
Aceclofenac-Galactose Conjugate: Design, Synthesis, Characterization, and Pharmacological and Toxicological Evaluations. Molecular pharmaceutics 15 (8) (2018)
Marialessandra Contino, Stefano Guglielmo, Maria Grazia Perrone, Roberta Giampietro, Barbara Rolando, Antonio Carrieri, Daniele Zaccaria, Konstantin Chegaev, Vanessa Borio, Chiara Riganti, Katarzyna Zabielska-Koczywąs, Nicola Antonio Colabufo, Roberta Fruttero
New tetrahydroisoquinoline-based P-glycoprotein modulators: decoration of the biphenyl core gives selective ligands. MedChemComm 9 (5) (2018)
Stefano Sainas, Agnese C Pippione, Elisa Lupino, Marta Giorgis, Paola Circosta, Valentina Gaidano, Parveen Goyal, Davide Bonanni, Barbara Rolando, Alessandro Cignetti, Alex Ducime, Mikael Andersson, Michael A Järvå, Rosmarie Friemann, Marco Piccinini, Cristina Ramondetti, Barbara Buccinnà, Salam Al-Karadaghi, Donatella Boschi, Giuseppe Saglio, Marco Lucio Lolli
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors. Journal of medicinal chemistry 61 (14) (2018)